Lantern Pharma Inc. Quarterly Return On Assets in % from Q1 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Lantern Pharma Inc. quarterly/annual Return On Assets history and growth rate from Q1 2021 to Q3 2024.
  • Lantern Pharma Inc. Return On Assets for the quarter ending September 30, 2024 was -51.2 %, a 80.2% decline year-over-year.
  • Lantern Pharma Inc. annual Return On Assets for 2023 was -32.2 %, a 44.4% decline from 2022.
  • Lantern Pharma Inc. annual Return On Assets for 2022 was -22.3 %, a 42.8% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -51.2 -22.8 -80.2% Jul 1, 2024 Sep 30, 2024
Q2 2024 -42.6 -17.6 -70.1% Apr 1, 2024 Jun 30, 2024
Q1 2024 -38.4 -15.4 -66.6% Jan 1, 2024 Mar 31, 2024
Q4 2023 -32.2 -9.89 -44.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -28.4 -7.1 -33.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -25 -2.38 -10.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -23.1 -4.5 -24.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 -22.3 -6.68 -42.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 -21.3 -3.46 -19.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -22.6 -4.61 -25.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -18.6 +2.32 +11.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -15.6 Oct 1, 2021 Dec 31, 2021
Q3 2021 -17.8 Jul 1, 2021 Sep 30, 2021
Q2 2021 -18 Apr 1, 2021 Jun 30, 2021
Q1 2021 -20.9 Jan 1, 2021 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.